Limited Value of 18F-2-Deoxyglucose Positron Emission Tomography to Detect Hepatocellular Carcinoma in Hepatitis B Virus Carriers

Hepato-Gastroenterology

Volumn 50, Issue 54, 2003, Pages 2154-2156

  Jeng, Long Bin ^a   Changlai, Sheng Pin ^b   Shen, Yeh You ^c,d   Lin, Cheng Chieh ^a   Tsai, Chang Hai ^e   Kao, Chia Hung ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d Taichung Hlthcare Mgmt and Univ   (Taiwan)

^e NONE

Author keywords

Fluorine 18 fluorodeoxyglucose; Hepatitis B virus carrier; Hepatocellular carcinoma; Positron emission tomography

Indexed keywords

ALPHA FETOPROTEIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; MORPHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0344099047     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Szmuness W, Harley E, Ikram: Sociodemographic aspects of the epidemiology of hepatitis B. In: Vyas GN, Gohen SN, Schmid R (Eds.). Viral Hepatitis. Philadelphia: Franklin Institute Press, 1978; pp. 297-323.
2. Tiollais P, Pourcel C, Dejean A: The hepatitis B virus. Nature 1985; 317:489-495.
3. Chen DS: Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In: Okuda k, Ishak K (Eds.). Neoplasms of the liver. Tokyo: Springer-Verlag, 1987; pp. 71-80.
4. Sung JL, Chen DS, Lai MY: Epidemiological study of hepatitis virus infection in Taiwan. Chinese J Gastroenterol 1984; 1:1-9.
5. Allgaier HP, Blum U, Deibert P, et al: Diagnosis of hepatocellular carcinoma. Schweiz Med Wochschr 1996; 126:1975-1983.
6. Zeuzem S, Roth WK, Herrmann G: Viral hepatitis C. Z Gastroenterol 1995; 33:117-132.
7. Huang GT, Sheu JC, Yang PM, et al: Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma study based on 420 patients. J Hepatol 1996; 25:334-348.
8. Sheu JC, Sung JL, Chen DS, et al: Ultrasonography of small hepatic tumors using high-resolution linear-array real time instruments. Radiology 1984; 150:797-802.
9. Yoshida T, Matsue H, Okazaki N, et al: Ultrasonographic differentiation of hepatocellular carcinoma from metastaic liver cancer. J Clin Ultrasound 1987; 15:431-437.
10. Combs CS, Lowe VJ, Wolverson MK, et al: Positron emission tomography (PET) scanning in the diagnosis of hepatocellular carcinoma (HCC). Hepatology 1997; 26(Suppl 1):A242.
11. Hör G, Adams S, Baum RP, et al: Impact of single photon emission computed tomography and positron emission tomography on diagnostic oncology. Diagn Oncol 1997; 4:297-321.
12. Rigo P, Paulus P, Kaschten BJ, et al: Oncological applications of positron emission tomography with fluorine-18-fluorodeoxyglucose. Eur J Nucl Med 1996; 23:1641-1674.
13. Torizuka T, Tamaki N, Inokuma T, et al: Value of fluorine-18-FDG PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994; 35:1965-1969.
14. Dimitrakopoulou-Strauss A, Gutzler F, Strauss LG, et al: PET studies with C-11 ethanol in intraumoral therapy of hepatocellular carcinomas. Radiology 1996; 36:744-749.
15. Schroder O, Trojan J, Zeurem S, et al: Limited value of fluorine-18-fluorodexyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection. Nuklearmedizin 1998; 37:279-285.
16. Okazumi S, Isono K, Enomoto K, et al: Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor and assessment of effect of treatment. J Nucl Med 1992; 33:333-339.
17. Oka H, Kurioka N, Kim K, et al: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990; 12:680-687.
18. Torizuka T, Tamaki N, Inokuma T, et al: In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med 1995; 36:1811-1817.
19. Wu HM, Hoh CK, Huang SC, et al: Quantification of serial tumor glucose metabolism. J Nucl Med 1996; 37:506-513.